ICE Formulations wants to be a considered as the premiere source for ‘interesting’ products; differentiating from competitors by developing products others won’t consider. With developments undertaken mainly in Asia-Pacific to keep costs to a minimum; projects for single markets or specific formulations are feasible, providing distinct commercial advantage to clients seeking to compete with superior portfolio depth.

• R&D through to registration file compilation
• Selection mainly from generic products <$100m brand sales
• Interest in products where patents have expired but there is no generic available
• Work with clients on product selection and licensing strategy to recover investment

Finished Dose Development
Active Ingredients development
Intellectual Property management

Flexible deal structures are commonplace; milestones, full-time-equivalents, royalties and profit -shares all considered.
Contact us for a list of current developments or to discuss a project. Click here for current developments.